| Activity-independent effects of CREB on neuronal survival and differentiation during mouse cerebral cortex development BS Landeira, TTS Santana, JAM Araújo, EI Tabet, BA Tannous, ... Cerebral Cortex 28 (2), 538-548, 2018 | 93 | 2018 |
| Olfactory ensheathing cells: a Trojan horse for glioma gene therapy LA Carvalho, J Teng, RL Fleming, EI Tabet, M Zinter, RA de Melo Reis, ... JNCI: Journal of the National Cancer Institute 111 (3), 283-291, 2019 | 29 | 2019 |
| Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition CC da Hora, K Pinkham, L Carvalho, M Zinter, E Tabet, I Nakano, ... Cell death discovery 5 (1), 72, 2019 | 28 | 2019 |
| Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF‐κB/STAT3 Signaling MW Schweiger, M Li, A Giovanazzi, RL Fleming, EI Tabet, I Nakano, ... Advanced biosystems 4 (12), 1900312, 2020 | 27 | 2020 |
| Obtusaquinone: a cysteine-modifying compound that targets Keap1 for degradation CE Badr, CC da Hora, AB Kirov, E Tabet, R Amante, S Maksoud, ... ACS chemical biology 15 (6), 1445-1454, 2020 | 19 | 2020 |
| A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo JCY Chien, E Tabet, K Pinkham, CC da Hora, JCY Chang, S Lin, CE Badr, ... Nucleic acids research 48 (17), e100-e100, 2020 | 16 | 2020 |
| Imaging tumor vascularity and response to anti-angiogenic therapy using Gaussia luciferase RS Kantar, G Lashgari, EI Tabet, GK Lewandrowski, LA Carvalho, ... Scientific Reports 6 (1), 26353, 2016 | 4 | 2016 |
| The natural compound obtusaquinone targets pediatric high-grade gliomas through ROS-mediated ER stress J Teng, G Lashgari, EI Tabet, BA Tannous Neuro-oncology advances 2 (1), vdaa106, 2020 | 3 | 2020 |
| Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition CC da Hora, K Pinkham, L Carvalho, M Zinter, E Tabet, I Nakano, ... Cell Death Discovery 5, 2019 | 1 | 2019 |
| Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma Therapy S Maksoud, MW Schweiger, EI Tabet, T Xiao, JE Hokayem, M Zinter, ... Molecular Neurobiology, 1-9, 2024 | | 2024 |
| TUMOR-EDUCATED PLATELETS GUIDE BREAST CANCER BRAIN METASTASIS AND PROMOTE THERAPEUTIC RESISTANCE E Tabet, B Tannous NEURO-ONCOLOGY 23, 199-199, 2021 | | 2021 |
| BSCI-04. Tumor-educated platelets promote breast cancer brain metastasis and therapeutic resistance E Tabet, B Tannous Neuro-oncology Advances 3 (Suppl 3), iii1, 2021 | | 2021 |
| Olfactory ensheathing glia as a cell-based therapy for glioblastomas L Carvalho, R Fleming, G Erel-Akbaba, G Lashgari, D Ryan, E Tabet, ... Cancer Research 81 (13_Supplement), 3114-3114, 2021 | | 2021 |
| Mesenchymal Transition: Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF‐κB/STAT3 Signaling (Adv. Biosys. 12/2020) MW Schweiger, M Li, A Giovanazzi, RL Fleming, EI Tabet, I Nakano, ... Advanced Biosystems 4 (12), 2070121, 2020 | | 2020 |
| STEM-15. SMALL BUT FIERCE: THE ROLE OF EXTRACELLULAR VESICLES IN MESENCHYMAL TRANSITION AND THERAPEUTIC RESISTANCE IN GLIOBLASTOMA M Schweiger, M Li, R Fleming, E Tabet, T Würdinger, B Tannous Neuro-Oncology 22 (Suppl 2), ii199, 2020 | | 2020 |
| Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas Through NF-kB/STAT3 Signaling MW Schweiger, M Li, R Fleming, E Tabet, B Tannous MOLECULAR THERAPY 28 (4), 510-510, 2020 | | 2020 |
| Multiplexed Bioluminescent Reporter Enables Non-Invasive Tracking of DNA Double Strand Break Repair Dynamics In Vitro and In Vivo JCY Chien, E Tabet, CC da Hora, JCY Chang, K Pinkham, S Lin, CE Badr, ... MOLECULAR THERAPY 28 (4), 284-284, 2020 | | 2020 |
| Abstract A054: Extracellular vesicles modulate glioblastoma intratumor heterogeneity and treatment resistance MW Schweiger, E Tabet, M Li, T Tian, M Zinter, R Fleming, LA Carvalho, ... Molecular Cancer Therapeutics 18 (12_Supplement), A054-A054, 2019 | | 2019 |
| Obtusaquinone is a cysteine-modifying compound that targets Keapl for degradation CC da Hora, E Tabet, CE Badr, B Tannous MOLECULAR CANCER THERAPEUTICS 18 (12), 2019 | | 2019 |
| Abstract A109: Repurposing low dose of quinoline methanol derivatives as a novel treatment for pediatric glioblastoma J Teng, L Carvalho, E Tabet, B Tannous Molecular Cancer Therapeutics 18 (12_Supplement), A109-A109, 2019 | | 2019 |
Tannous BAMassachusetts General Hospital and Harvard Medical School在 hms.harvard.edu 的电子邮件经过验证
